DE2627914A1 - Arzneimittel mit antiphlogistischer wirkung - Google Patents

Arzneimittel mit antiphlogistischer wirkung

Info

Publication number
DE2627914A1
DE2627914A1 DE19762627914 DE2627914A DE2627914A1 DE 2627914 A1 DE2627914 A1 DE 2627914A1 DE 19762627914 DE19762627914 DE 19762627914 DE 2627914 A DE2627914 A DE 2627914A DE 2627914 A1 DE2627914 A1 DE 2627914A1
Authority
DE
Germany
Prior art keywords
quinazolinone
medicament according
phenyl
deep
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762627914
Other languages
German (de)
English (en)
Inventor
Hiroshi Awata
Toshiaki Komatsu
Hisao Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2627914A1 publication Critical patent/DE2627914A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762627914 1975-06-23 1976-06-22 Arzneimittel mit antiphlogistischer wirkung Withdrawn DE2627914A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58957375A 1975-06-23 1975-06-23

Publications (1)

Publication Number Publication Date
DE2627914A1 true DE2627914A1 (de) 1977-01-13

Family

ID=24358582

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762627914 Withdrawn DE2627914A1 (de) 1975-06-23 1976-06-22 Arzneimittel mit antiphlogistischer wirkung

Country Status (11)

Country Link
JP (1) JPS521036A (enExample)
AU (1) AU499021B2 (enExample)
BE (1) BE843242A (enExample)
CA (1) CA1062615A (enExample)
DE (1) DE2627914A1 (enExample)
FR (1) FR2315281A1 (enExample)
GB (1) GB1507804A (enExample)
IL (1) IL49867A (enExample)
NL (1) NL7606494A (enExample)
NZ (1) NZ181221A (enExample)
ZA (1) ZA763700B (enExample)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1251600A (enExample) 1968-07-18 1971-10-27
US3712892A (en) 1969-08-02 1973-01-23 Sumitomo Chemical Co Quinazolinone derivatives
GB1307202A (en) 1971-06-15 1973-02-14 Sumitomo Chemical Co Quinazoline derivative a process for producing them and compositions containing them
US3859237A (en) 1970-04-20 1975-01-07 Sumitomo Chemical Co Quinazoline derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1251600A (enExample) 1968-07-18 1971-10-27
US3712892A (en) 1969-08-02 1973-01-23 Sumitomo Chemical Co Quinazolinone derivatives
US3859237A (en) 1970-04-20 1975-01-07 Sumitomo Chemical Co Quinazoline derivatives
GB1307202A (en) 1971-06-15 1973-02-14 Sumitomo Chemical Co Quinazoline derivative a process for producing them and compositions containing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
IL49867A0 (en) 1976-08-31
BE843242A (fr) 1976-10-18
NZ181221A (en) 1978-04-28
AU1506676A (en) 1977-12-22
GB1507804A (en) 1978-04-19
IL49867A (en) 1980-01-31
CA1062615A (en) 1979-09-18
NL7606494A (nl) 1976-12-27
JPS521036A (en) 1977-01-06
AU499021B2 (en) 1979-04-05
FR2315281B1 (enExample) 1979-04-27
FR2315281A1 (fr) 1977-01-21
ZA763700B (en) 1977-05-25
JPS5416509B2 (enExample) 1979-06-22

Similar Documents

Publication Publication Date Title
DE60024588T2 (de) Substituierte porphyrine und deren therapeutische verwendungen
DE69008472T2 (de) (2-Imidazolin-2-ylamino)-tetrahydro-chinoxaline und Anwendungsverfahren.
DE2815578C2 (de) Neue pharmazeutische Verwendung von Nimodipin
DE3409801A1 (de) Thiazolidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0529500B1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen
DE19523502A1 (de) Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE69500673T2 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
DE3012862A1 (de) Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE2624558A1 (de) Arzneimittel mit analgetischer wirkung
DE3446371A1 (de) 5-pyrimidincarboxamide und 5-pyrimidinthiocarboxamide und ihre verwendung zur behandlung von leukaemie und tumoren
DE2740281A1 (de) Verwendung von 4-carbamoyl-5-hydroxyimidazol bei der behandlung von krebs, rheumatismus und nephritis
EP0761650A1 (de) Thermostabile und lagerfähige Kristallmodifikation von N-Methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl-acetamid und Verfahren zu dessen Herstellung
DE3843324A1 (de) Neue verwendung von brenzkatechin-0-methyl-transferase (comt)-inhibitoren und ihre physiologisch annehmbaren salze und ester
DE3619426A1 (de) Mittel zur erhoehung der widerstandskraft gegen erkaeltungskrankheiten bei patienten mit eingeschraenkter lungenfunktion
EP0314984B1 (de) Verwendung von 2-Pyrimidinyl-1-piperazin-Derivaten
DE2609746A1 (de) Piperazinverbindungen sowie arzneimittel, die diese verbindungen enthalten
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE2236876A1 (de) N-substituierte aminosaeuren mit wirkungen gegen viren, entzuendungen und/oder tumoren
DD145266A5 (de) Verfahren zur herstellung von 6-methoxy-2-acetylnaphthalinoxim-derivaten
US4247554A (en) Method for the prevention of gastro-intestinal ulcer caused by a non-steroidal anti-inflammatory agent
DE69007439T2 (de) Mittel gegen Tumore.
DE2324633A1 (de) 2-eckige klammer auf (1-benzylcyclopentyl)-imino eckige klammer zu -pyrrolidin, verfahren zu seiner herstellung und diese verbindung enthaltende therapeutische zubereitungen
DE10138561A1 (de) Tumorhemmende Cerverbindungen
DE2227487C3 (de) Derivate von 3-Äthoxycarbonyl-S-hydroxy-2-methyl-4-piperazinomethyl-indol, Verfahren zu ihrer Herstellung und Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee